key: cord-1029872-czign5pq
authors: Apata, Ibironke W.; Kabbani, Sarah; Neu, Alicia M.; Kear, Tamara M.; D’Agata, Erika M.C.; Levenson, David J.; Kliger, Alan S.; Hicks, Lauri A.; Patel, Priti R.
title: Opportunities to Improve Antibiotic Prescribing in Outpatient Hemodialysis Facilities
date: 2020-10-10
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.08.011
sha: a47a8fc467406b0d1b8d1b1d85f8ac8988dbc875
doc_id: 1029872
cord_uid: czign5pq

Antibiotic use is necessary in the outpatient hemodialysis setting, as patients on hemodialysis are at increased risk for infections and sepsis. However, inappropriate antibiotic use can lead to adverse drug events, including adverse drug reactions and infections with Clostridioides difficile and antibiotic-resistant bacteria. Optimizing antibiotic use can decrease adverse events and improve infection cure rates and patient outcomes. The American Society of Nephrology (ASN) and the Centers for Disease Control and Prevention (CDC) created the Antibiotic Stewardship in Hemodialysis White Paper Writing Group, comprising experts in antibiotic stewardship, infectious diseases, nephrology, and public health, to highlight strategies that can improve antibiotic prescribing for patients on maintenance hemodialysis. Based on existing evidence and the unique patient and clinical setting characteristics, the following strategies for improving antibiotic use are reviewed: expanding infection and sepsis prevention activities, standardizing blood culture collection processes, treating methicillin-susceptible Staphylococcus aureus infections with β-lactams, optimizing communication between nurses and prescribing providers, and improving data sharing across transitions of care. Collaboration between CDC, ASN, other professional societies such as infectious diseases, hospital medicine and vascular surgery societies, and dialysis provider organizations can improve antibiotic use and the quality of care for patients on maintenance hemodialysis.

The discovery of antibiotics has revolutionized the practice of medicine and saved countless lives. However, unnecessary antibiotic use contributes to the spread of antibiotic-resistant bacteria 1 , jeopardizes patient safety and can lead to adverse drug events, 1,2 such as Clostridioides difficile infection, 1,3 without the intended clinical benefit. The Centers for Disease Control and Prevention (CDC) estimates that more than 2.8 million people in the United States suffer from an antibiotic-resistant infection each year, and at least 35,000 people die as a result. 4 Studies have suggested that end-stage renal disease requiring dialysis is an independent risk factor for C. difficile infections. 5, 6 In addition, patients on maintenance hemodialysis have a high prevalence of infection and/or colonization with multidrug-resistant organisms (MDROs) [7] [8] [9] and substantial mortality resulting from infections and sepsis. 10 Sepsis is a life-threatening organ dysfunction due to a person's dysregulated response to infection. 11 Optimizing antibiotic use can play an important role in improving infection cure rates, preventing sepsis, reducing the unintended negative consequences of antibiotic use and possibly reducing costs. 12 The Antibiotic Stewardship in Hemodialysis (ASHD) White Paper Writing Group is a collaboration between CDC and the American Society of Nephrology (ASN). Given nationwide interest in optimizing antibiotic use in various patient populations, the objectives of the workgroup were to summarize current literature on antibiotic use in the outpatient hemodialysis setting and highlight strategies to improve antibiotic prescribing in hemodialysis. We focused on intravenous (IV) antibiotic use because of the lack of published data on oral antibiotic use in this population in the United States. This document is not intended as guidelines or recommendations due to limited existing evidence on the topic, and is intended for outpatient hemodialysis care, including home hemodialysis, but may also be relevant to inpatient hemodialysis care. The J o u r n a l P r e -p r o o f 4 intended target audience includes kidney care providers, public health officials, patient safety officers, healthcare epidemiologists, and antibiotic stewardship experts.

The ASHD workgroup had eight phone call meetings over an 18-month period. Initial meetings involved discussing a framework for the white paper and developing an outline of key areas the white paper would address. A literature search was performed concurrently using PubMed and Google Scholar to identify published articles on antibiotic use or antibiotic stewardship in dialysis settings. A summary of the literature review was presented to the group and generated discussion on study findings, data quality and strategies to improve antibiotic prescribing.

Leaders from some dialysis organizations were invited to present their antibiotic stewardship activities to the workgroup. The workgroup members wrote assigned sections of the paper based on their areas of expertise. These sections were collated and synthesized into a cohesive manuscript. The final manuscript was reviewed and approved by workgroup members and their respective organizations (i.e., CDC and ASN).

In the United States, there are approximately 468,000 patients on maintenance hemodialysis and 52,000 patients on peritoneal dialysis. 10 Ninety-eight percent of patients on maintenance hemodialysis receive dialysis in outpatient dialysis facilities, while the remaining two percent (9,000 patients) receive dialysis at home. 10 Patients on maintenance hemodialysis have a high comorbidity burden from diseases such as diabetes, cardiovascular disease, stroke, and peripheral vascular disease. 13 These comorbidities and advanced age place them at increased risk for lower extremity ischemia, ulceration, and skin and soft tissue infection. 14 Patients on maintenance J o u r n a l P r e -p r o o f 5 hemodialysis are also at increased risk of acquiring infections because of an impaired immune system, 15 frequent accessing of the bloodstream during hemodialysis, and use of hemodialysis central venous catheters (CVC). 16, 17 Infection is the second leading cause of death in this population and sepsis accounts for the majority of these deaths. 10 Approximately 13,000 patients on maintenance hemodialysis died from sepsis from 2015 through 2017. 10 Given this high infection burden, it is not surprising that antibiotic exposure is common among patients on maintenance hemodialysis. At least 30 percent of patients on maintenance hemodialysis receive one or more doses of IV antibiotics in a given year. 18, 19 Improving antibiotic prescribing to ensure that the "right antibiotic is prescribed for the right diagnosis, at the right dose and duration," while avoiding unnecessary antibiotic use, can potentially improve clinical outcomes for patients on maintenance hemodialysis. 6

Antibiotic stewardship is defined as the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients. 20 Improving antibiotic prescribing and use is critical to effectively treat infections, protect patients from harms caused by unnecessary antibiotic use, and combat antibiotic resistance. 20 Antibiotic stewardship includes measuring how antibiotics are prescribed and implementing effective strategies to align prescribing practices with evidence-based guidelines. 20 (Box 1) Improving antibiotic prescribing intersects with initiatives to improve sepsis detection and treatment such as procedures and tools to enhance identification of causative organisms to optimize antibiotic selection. 11 Interventions designed to improve antibiotic prescribing practices for hospitalized patients have been found to increase compliance with antibiotic use policies, decrease the duration of therapy, and reduce hospital J o u r n a l P r e -p r o o f 6 length of stay. 21 A systematic review and meta-analysis of 145 studies examining outcomes of antibiotic stewardship interventions in the hospital setting found that guideline-adherent empirical antibiotic therapy and de-escalation of therapy (i.e., streamlining empirical treatment based on culture results) 21 were associated with a reduction in mortality. 22 Another systematic review and meta-analysis demonstrated that antibiotic stewardship programs in hospitals reduced the incidence of infection and colonization with MDROs, and C. difficile infection. 23 CDC developed the Core Elements of Antibiotic Stewardship to provide a framework for implementing stewardship programs and activities, and for monitoring and improving antibiotic use. 24, 25 The Core Elements have been developed for different healthcare settings, including acute care hospitals, nursing homes, and critical access hospitals, to address unique setting characteristics and patient needs. [24] [25] [26] In 2016, the Core Elements were adapted for outpatient clinicians and facilities that routinely provide antibiotic treatment but these were not intended to address the outpatient hemodialysis setting, 24 Outpatient hemodialysis facilities and the patient population receiving care in these facilities have unique characteristics that may be pertinent when considering antibiotic stewardship activities such as patient care characteristics and care context, facility staffing, transitions of care, and guidelines and standards. (Figure 1 )

In the published literature, there are four studies based on national surveillance data that describe antibiotic use in outpatient hemodialysis facilities in the United States. 7, 19, 27, 28 In addition, there are several small observational studies of a limited number of U.S. outpatient dialysis facilities describing antibiotic use 18, 29 , characterizing appropriateness of antibiotic use 18, 30, 31 and/or J o u r n a l P r e -p r o o f 7 assessing the effectiveness of antibiotic stewardship interventions 32 . Appropriateness of antibiotic use has also been described in the outpatient hemodialysis setting in Canada and Australia 33, 34 and an inpatient hemodialysis unit in the United States. 35 (Table 1 )

Antibiotic use data from the United States Renal Data System and a separate small study suggest that 30 percent of patients on maintenance hemodialysis receive at least one intravenous (IV) antibiotic dose in U.S. outpatient hemodialysis facilities each year. 18, 19 In 2014, data from over 6,000 outpatient hemodialysis facilities reporting to the National Healthcare Safety Network (NHSN) revealed a facility median of 3.0 IV antimicrobial starts per 100 patient-months (interquartile range: 1.91-4.25). 7 NHSN captures IV antimicrobial starts only, not all antimicrobial doses. Antibiotic use varies across dialysis facilities, with some facilities having a higher rate of antibiotic use than others. 7,18 Differences in infection rates, prescribing practices, and patient characteristics may play a role in the variations seen in antibiotic start rates in these studies. 7, 18 For example, IV antimicrobial starts were higher in patients with central venous catheters (CVC) than in those with arteriovenous grafts or fistulas, 7 as would be expected based on the higher infection rates in seen in patients with CVC.

Vancomycin is the most commonly used IV antibiotic in outpatient dialysis facilities 18, 19, 32 ; of patients on hemodialysis in the U.S. who received outpatient IV antibiotics in 2007, 68 percent received vancomycin. 19 Vancomycin also accounts for the highest percentage (over 70%) of IV antimicrobial starts. 7, 27, 28 In contrast, a study conducted in outpatient and inpatient hemodialysis facilities in Hawaii, found cefazolin was the most commonly used IV antibiotic, followed by vancomycin. 29 Third generation cephalosporins and aminoglycosides are also commonly used in the outpatient dialysis setting. 18, 19, 29, 32 J o u r n a l P r e -p r o o f 8 

Studies assessing the appropriateness of antibiotic use in a small number of outpatient hemodialysis facilities have demonstrated that up to 37 percent of IV antibiotic courses 33 or 30 percent of IV antibiotic doses 18 were inappropriate or unnecessary. In a study of two dialysis facilities, Snyder et al. found that approximately 60 percent of patients who received IV antibiotics in a 12-month period received at least one dose that was not indicated. 30 They also demonstrated that continued doses (compared to first doses and surgical prophylactic doses) comprised the highest proportion of inappropriate antibiotic doses. 18 Similarly, Zvonar et al. studied vancomycin prescribing in three outpatient dialysis facilities and determined that the majority (88%) of initial or empiric courses of vancomycin were appropriate, but this percentage decreased (63%) when assessed after culture and sensitivity results were available. 33 These two studies highlighted common reasons antibiotics were considered inappropriate: failure to meet standard clinical criteria (e.g., defined through national guidelines) for bloodstream infections, soft tissue infections or surgical prophylaxis; 18 failure to discontinue antibiotics based on negative culture results; 33 failure to narrow antibiotic spectrum from vancomycin to βlactams 18, 33 or from third and fourth generation cephalosporins to cefazolin when appropriate; 18 and failure to comply with recommended antibiotic duration for surgical prophylaxis. 18 Substantial variations in antibiotic prescribing practices have been observed across facilities.

Snyder et al revealed that the majority of inappropriate antibiotic doses for surgical prophylaxis was from one of two dialysis facilities studied. 18 Vancomycin was the most commonly inappropriately prescribed IV antibiotic, likely reflecting its overall burden of use. 18 In a study involving outpatient and inpatient dialysis facilities in Australia where vancomycin use was low, cefazolin was found to be the most commonly inappropriately prescribed IV antibiotic among J o u r n a l P r e -p r o o f 9 patients on hemodialysis. Patient factors associated with receipt of an antibiotic dose that was not indicated included use of dialysis CVC, and longer duration of hemodialysis dependence. 30 Inadequate medical record documentation 18 (e.g., antibiotic indication) and failure to obtain blood cultures prior to initiating antibiotics are recognized barriers to fully evaluating the appropriateness of antibiotic doses. 33 Studies describing antibiotic use and appropriateness in patients on maintenance hemodialysis are subject to several limitations. First, the results might not be generalizable given small sample size. Substantial variations in antibiotic prescribing practices observed between two facilities in the same study underscores this (e.g., 91% of antibiotic doses that were considered inappropriate due to failure to meet criteria for surgical prophylaxis were prescribed in facility B). 18 from the standard of ≥100.4°F to ≥100°F to address the immune dysfunction observed in patients on hemodialysis. 18 Such antibiotic appropriateness criteria, which varied across studies, must be considered when interpreting study results.

Given limited evidence for antibiotic stewardship interventions in the dialysis setting, the ASHD Writing Group proposed "Suggested Strategies" based on expert opinion in lieu of evidencebased guidelines. (Figure 2 ) We prioritized this group of interventions, "Suggested Strategies for Improving Antibiotic Use in Outpatient Hemodialysis," that may have broader benefits beyond stewardship, in particular, when a recommendation for the intervention already exists for patient safety reasons. In addition, we describe additional "Strategies used in other healthcare settings" that can help to inform stewardship efforts in dialysis settings.

An important strategy to reduce the need for antibiotics is to prevent infections and resultant sepsis from occurring. Dialysis facilities should routinely engage in activities to prevent bloodstream and vascular access infections, and maximize delivery of recommended vaccines (e.g., influenza, pneumococcal). 37 Collection of blood cultures prior to delivery of antibiotics for suspected bloodstream infections is a recommended practice 40,41 that allows for the adjustment of empiric antibiotic therapy based on culture results. Written protocols outlining when blood cultures should be obtained, and the procedure to obtain them can help ensure they are collected prior to antibiotic delivery and that false-positives and false-negatives are minimized. Educating personnel who collect blood samples for culture about recommended procedures, and periodically assessing their competency are necessary adjuncts to ensure implementation of best practice. 42, 43 It is generally recommended that at least two sets of cultures of appropriate blood volume be collected, ideally from two separate sites, with a set consisting of both aerobic and anaerobic blood culture bottles. 44, 45 The collection of more than one blood culture set increases the blood volume that is cultured and, when drawn from a different site, helps to distinguish contamination from infection. 44, 46 For patients on hemodialysis, the sites from which cultures are often obtained include the hemodialysis catheter hub(s), the hemodialysis circuit (i.e., port within the tubing Receiving In-Center Hemodialysis Guide that outlines best blood culturing practices for hemodialysis patients, along with the supporting rationale. 45 The NTDS guide may be a helpful resource for practice improvement in this area.

As highlighted in the evidence summary, a common form of inappropriate antibiotic use is 

Several interventions such as accountable justification, 53 prospective audits and feedback, 25, 54 and audit and feedback combined with peer comparison 53, 55 have been shown to improve antibiotic prescribing in other (non-dialysis) healthcare settings. 21,56 (Box 1) Implementing evidence-based clinical decision support protocols for the initiation of antibiotics may be an effective strategy to improve prescribing practices. 57 Providing antibiotic order forms or electronic order sets that incorporate clinical decision support drawn from evidence-based guidelines can be considered in the dialysis setting such as reminders to obtain blood cultures prior to ordering IV antibiotics. 18 

Considering that continuing doses, not empiric therapy, account for the majority of inappropriate doses in dialysis patients, 18 implementing a post-prescription review or an antibiotic time-out may help prevent inappropriate use. 60 (Box 1) In addition, evaluating a patient's clinical progress and reassessing antibiotic therapy is a recommended sepsis prevention and management effort. 11 An antibiotic time-out is a provider-led reassessment of an antibiotic course after treatment initiation. 25 This allows clinicians to decide whether discontinuation, de-escalation or adjustment of empiric therapy based on clinical response and the results of diagnostic testing is necessary, and determine the duration of therapy. Successful antibiotic time-out implementation relies upon effective communication across transitions of care, so that microbiology results from transferring facilities are available for review.

Outpatient dialysis facilities may explore opportunities to establish relationships with infectious diseases physicians or pharmacists who can serve as resources on best prescribing practices.

These professionals can provide expertise in the diagnosis and treatment of relevant infections, and in developing processes and protocols for antibiotic dosing, selection, adjustment and deescalation. Whether relationships with such experts are established at the facility or larger organizational level may depend on available resources.

Engaging leadership at the local facility and the larger organizational level is important to the success of antibiotic stewardship interventions in the dialysis setting. 32, 61 Leadership support can J o u r n a l P r e -p r o o f 16 signal that antibiotic stewardship activities are an organizational priority, and ensure that needed resources are provided for antibiotic prescribing and stewardship expertise, education for staff and patients, and development and promotion of antibiotic prescribing pathways and protocols.

Clinician education is an essential component of any antibiotic stewardship activity. 24 Education topics should include: early sepsis prevention and management, 11 blood culture collection procedures, 44 antibiotic selection and dosing for empiric treatment of common infections, and antibiotic adjustment based on microbiology data. However, numerous studies have shown that education alone does not change behavior and should be paired with other interventions to improve prescribing practices. 56 Education through academic detailing (i.e., peer-to-peer interactive educational outreach providing evidence-based material and opportunities for dialogue) is more effective than passive didactic-type education. 62 Staff should be given the opportunity to voice concerns, discuss perceived barriers to improving antibiotic prescribing practices, and adapt antibiotic stewardship policies to the needs of the dialysis facility. Effectively engaging medical directors is important for the success of these efforts and could ensure that the activities receive appropriate attention from clinical staff and leadership.

While immediate actions can be taken to improve antibiotic use among dialysis patients, further research is needed to inform and refine future antibiotic stewardship initiatives. 

Antibiotic stewardship is defined as the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients.

Evidence-based protocols and standardized checklists for initiating antibiotic. Antibiotic use protocols can include clinical decision support and prompt clinicians to justify or explain the indication for an antibiotic order (Accountable Justification).

Reviewing culture results and response to therapy after treatment initiation (Antibiotic Time-out) to determine appropriate treatment and duration needed.

Monitoring antibiotic use practices to guide and evaluate interventions.

Reporting prescribing practices back to providers to facilitate practice change. 

• Identify and refine measures to distinguish optimal versus inadequate or unnecessary antibiotic use in the hemodialysis population.

• Comparative effectiveness studies of stewardship interventions • Cost-effectiveness studies of specific stewardship interventions • Assessment of patient preferences to inform antibiotic use guidelines and policies

• Biomarkers for sepsis in hemodialysis patients to improve early detection of severe infections and assist in targeting empiric antibiotics.

• Data on all antibiotics (including oral) prescribed to patients on dialysis in all healthcare settings to better target improvement efforts.

• Guidelines for evaluation and treatment of common infections in hemodialysis patients and antibiotic prophylaxis for dialysis vascular access procedures to optimize antibiotic use and standardize definitions. • Patients on hemodialysis are medically complex with high rates of sepsis.

• Unlike patients treated in acute care settings, dialysis outpatients are not under close clinical monitoring between dialysis treatments.

• When away from the dialysis facility, nephrologists rely on nurses' or advance practice providers' (eg nurse practitioners) reports to determine the need to initiate antibiotics.

• Dialysis facilities often lack established relationships with infectious diseases specialists and pharmacists to assist with antibiotic prescribing.

• Patients on hemodialysis frequently receive care in multiple healthcare settings (eg outpatient dialysis facility and acute care hospital).

• Transfer of medical information (including microbiology culture results) during transitions of care is a recognized challenge to care coordination.

• Gaps in guidelines and standards exist for diagnosing and treating infections in the hemodialysis population. • Implement influenza vaccine campaign.

• Involve patients in hand hygiene observations

• Train staff on how blood culture should be obtained (e.g. sites of collection, blood volume). • Evaluate adherence to blood culture collection prior to antibiotic initiation.

• Incorporate automated alert in electronic medical record to prompt providers to review appropriateness of antibiotic therapy.

• Develop a process to receive and notify providers of culture results.

• Develop a structed method of communicating critical information such as SBAR (Situation, Background, Assessment and Recommendation).

• Work with local hospitals to establish data sharing agreements for bidirectional communication.

• Implement standard transfer form/sign out between dialysis facility and nursing home. 

Association of Adverse Events With Antibiotic Use in Hospitalized Patients

US Emergency Department Visits for Outpatient Adverse Drug Events

Risk factors for Clostridium difficile infection

Antibiotic Resistance Threats in the United States

Chronic kidney disease as a risk factor for Clostridium difficile infection

Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors

National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014

Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Combatting Sepsis: A Public Health Perspective

Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model

An improved comorbidity index for outcome analyses among dialysis patients

Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: a collaboration between dermatologists and infectivologists

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the Clinical Performance Measures and US Renal Data System projects

Septicemia in dialysis patients: incidence, risk factors, and prognosis

Antimicrobial use in outpatient hemodialysis units

Outpatient IV antibiotic use in the U.S. hemodialysis population

Interventions to improve antibiotic prescribing practices for hospital inpatients

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis

Core Elements of Outpatient Antibiotic Stewardship

Centers for Disease Control and Prevention. Implementation of Antibiotic Stewardship Core Elements at Small and Critical Access Hospitals

Dialysis Event Surveillance Report: National Healthcare Safety Network data summary

Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for

Burden of infection in patients with end-stage renal disease requiring long-term dialysis

Factors associated with the receipt of antimicrobials among chronic hemodialysis patients

Inappropriate intravenous antimicrobial starts: An antimicrobial stewardship metric for hemodialysis facilities

The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities

Assessment of vancomycin use in chronic haemodialysis patients: room for improvement

Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study

Vancomycin prescribing practices in hospitalized chronic hemodialysis patients

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD

Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients

Guidelines for Vaccinating Kidney Dialyis Patients and Patients with Chronic Kidney Disease

Hemodialysis catheter care strategies: a cluster-randomized quality improvement initiative

Clinician Guide for Collecting Cultures. #p1

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

Principles of Evaluating Nursing Competence

Measuring the Competence of Healthcare Providers. Operations Research Issue Paper. US Agency for International Development (USAID) by the Quality Assurance (QA) Project

Identifying and classifying bloodstream infections among hemodialysis patients

Nephrologists Transforming Dialysis Safety. Standardization of Blood Culture Collection for Patients Receiving In-Center Hemodialysis. , 2020. 46. Clinical and Laboratory Standards Institute. Principles and Procedures for Blood Cultures: Approved Guidelines. . CLSI Document M47-A

Recommended Clinical Trial End Points for Dialysis Catheters

Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillinsusceptible Staphylococcus aureus bacteremia

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

The human factor: the critical importance of effective teamwork and communication in providing safe care. Qual Saf Health Care

Impact of the communication and patient hand-off tool SBAR on patient safety: a systematic review

Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

Effects of Behavioral Interventions on Inappropriate Antibiotic Prescribing in Primary Care 12 Months After Stopping Interventions

Advances in optimizing the prescription of antibiotics in outpatient settings

A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America

Measuring Appropriate Antimicrobial Use: Attempts at Opening the Black Box

Implementing an antimicrobial stewardship program in out-patient dialysis units

Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practices

The medical director and quality requirements in the dialysis facility

Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network